Effects of Fhytomenadione on Coronary Artery Calcification of Hemodialysis Patients

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 7, 2017

Primary Completion Date

September 27, 2019

Study Completion Date

January 2, 2020

Conditions
Coronary Calcification
Interventions
DRUG

phytomenadione

phytomenadione 10 mg (1 vial in the venous line of the extracorporeal hemodialysis circuit) post hemodialysis 3 times a week for 12 months

DRUG

placebo solution

1 vial of placebo solution (solution for injection in the venous line of the extracorporeal hemodialysis circuit) post hemodialysis 3 times a week for 12 months

Trial Locations (1)

37260

Hospital de Alta Especialidad No. 1 Bajío, Boulevard Adolfo López Mateos esquina Insurgentes S/N, colonia Los Paraísos, León

All Listed Sponsors
collaborator

Marco Antonio Ocampo Apolonio

UNKNOWN

collaborator

Rodolfo Guardado Mendoza

UNKNOWN

collaborator

Texar Alfonso Pereyra Nobara

UNKNOWN

lead

Instituto Mexicano del Seguro Social

OTHER_GOV

NCT04247087 - Effects of Fhytomenadione on Coronary Artery Calcification of Hemodialysis Patients | Biotech Hunter | Biotech Hunter